Shinya Sato

9PUBLICATIONS
16CO-AUTHORS
Cell physiologyClinimetricsMetabolic medicineCondensed matter characterisation technique developmentMedical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 13, 2026
Response to "Comment on 'Using Serum Creatinine-To-Cystatin C Ratio to Predict Sarcopenia in Patients With Liver Cirrhosis'".

|Feb 27, 2026
Creatinine/Cystatin C Ratio as a Surrogate Marker for Sarcopenia in Hepatitis-C-Associated Liver Cirrhosis After Achieving a Sustained Virologic Response.

Aritoshi Koizumi, Tadashi Namisaki, Akihiko Shibamoto

|Dec 30, 2025
Diabetes as a Risk Factor for Sarcopenia in Patients with MASH-Related Cirrhosis.

Shinya Sato, Hiroaki Takaya, Tadashi Namisaki

|Oct 16, 2025
Creatinine-to-Cystatin C Ratio Combined with FIB-4 and ELF for Noninvasive Fibrosis Assessment in MASLD.

Masafumi Oyama, Tadashi Namisaki, Akihiko Shibamoto

|Sep 13, 2025
Efficacy of an Endoscopic Device Integrating a Sphincterotome and a Dilation Balloon Catheter for the Treatment of Choledocholithiasis (with Video).

Jun-Ichi Hanatani, Koh Kitagawa, Shohei Asada

|Jul 29, 2025
Rifaximin Attenuates Liver Fibrosis and Hepatocarcinogenesis in a Rat MASH Model by Suppressing the Gut-Liver Axis and Epiregulin-IL-8-Associated Angiogenesis.

Naoki Nishimura, Kosuke Kaji, Norihisa Nishimura

Pageof 2

Frequent Collaborators

9 joint publications

Tadashi Namisaki

7 joint publications

Norihisa Nishimura

7 joint publications

Koh Kitagawa

5 joint publications

Yukihisa Fujinaga